Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 5,910.00
+90.00 (1.55%)
Sep 4, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 32.68 billion as of September 4, 2026. Its market cap has decreased by -41.66% in one year.
Market Cap
32.68B
Enterprise Value
18.82B
Revenue
32.90B
Ranking
n/a
PE Ratio
6.07
Stock Price
5,910.00
ChartMarket Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 32.68B, a decrease of -88.63%. That is a compound annual growth rate of -65.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 32.68B | -40.00% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.41T |
| Celltrion | 44.71T |
| ALTEOGEN | 20.78T |
| Samsung Epis Holdings | 9.04T |
| MYUNGMOON Pharm co.,Ltd | 42.39B |
| IMB Dx | 41.49B |
| HASS Corp. | 38.73B |
| LabGenomics | 37.12B |